SCHEMBL23866983

SCHEMBL23866983

CCCCC(CCCC)Cc1ccc(C(=O)OC)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.51
CYP4A11 Q02928 2/20 0.51
CYP4F2 P78329 1/20 0.50
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
CASP1 P29466 1/20 0.48
ALDH1A1 P00352 2/20 0.47
LMNA P02545 1/20 0.47
CYP3A4 P08684 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ERAP2 Q6P179 2/20 0.46
LNPEP Q9UIQ6 2/20 0.46
MGLL Q99685 1/20 0.46
MAPT P10636 3/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
SLC6A3 Q01959 1/20 0.45
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7614719 0.88 CYP4A11 (0.50) LOXL2CYP4A11CYP4F2NPC1RAB9A
SCHEMBL7622296 0.86 CYP4A11 (0.54) LOXL2CYP4A11CYP4F2NPC1RAB9A
SCHEMBL25336125 0.86 CYP4A11 (0.44) LOXL2CYP4A11CYP4F2NPC1RAB9A
SCHEMBL25464956 0.84 LOXL2 (0.51) LOXL2CYP4A11CYP4F2NPC1RAB9A
SCHEMBL6653642 0.83 ALDH1A1 (0.52) ALDH1A1LMNACYP3A4HSD17B10CA2
SCHEMBL28867145 0.82 MGLL (0.40) LOXL2CYP4A11CYP4F2NPC1RAB9A
SCHEMBL19717723 0.81 TSHR (0.42) ALDH1A1LMNACYP3A4HSD17B10MAPT
SCHEMBL28063313 0.81 CYP4A11 (0.51) LOXL2CYP4A11CYP4F2NPC1RAB9A
SCHEMBL10800514 0.80 ALDH1A1 (0.49) CYP4A11CYP4F2ALDH1A1LMNACYP3A4
SCHEMBL6658753 0.80 ALDH1A1 (0.55) NPC1RAB9AALDH1A1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210300903-A1 SIGMA RECEPTOR BINDERS UNIV TEXAS (US) 2021-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300903-A1 SIGMA RECEPTOR BINDERS SIGMAR1, OPRK1, OPRL1 LOXL2 3192/4885CYP4A11 3291/4885CYP4F2 3855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.